NEW YORK (TheStreet) -- RATINGS CHANGES Biogen Idec was downgraded to hold from buy at Stifel. Valuation call, as some potential risks loom on the horizon, Stiefel said. Darden was upgraded at Telsey Advisory to market perform from outperform. Twelve-month price target is $77. Estimates were also increased as the company is cutting costs, Telsey Advisory said. Nvidia was downgraded at Goldman Sachs to sell from neutral. Twelve-month price target is $20. Company is seeing slower core demand and faces a licensing risk, Goldman Sachs said. Carnival was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $51. Company is facing material currency risks, Deutsche Bank said. EMC was downgraded at Piper Jaffray to neutral from overweight. Twelve-month price target is $27. Company is facing increased competition, Piper Jaffray said. NetApp was downgraded at Piper Jaffray to neutral from overweight. Twelve-month price target is $36. Estimates also cut, as the company is facing increased competition, Piper Jaffray said. Must Read: 10 Stocks Carl Icahn Loves for 2015: Apple, eBay, Hertz and More Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here. Follow TheStreet on Twitter and become a fan on Facebook.
Click to view a price quote on BIIB. Click to research the Drugs industry.
from Latest TSC Headlines http://ift.tt/1xUj5T4
No comments:
Post a Comment